The Uttarakhand Drugs Controller has cancelled the manufacturing licence of Themis Medicare for diclofenac sodium injection 75 mg/ml using Transcutol-P and directed the company to recall the product ...
New Delhi: India’s drug regulator has ordered the withdrawal of the popular diclofenac painkiller injection marketed by Novartis India Ltd and made by Themis Medicare Ltd, following safety concerns ...
The Delhi High Court dismissed a petition filed by Themis Medicare challenging the ban imposed by the Drug Controller General of India (DCGI) on Diclofenac injection 75 mg/1ml marketed by its partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback